Overview

China Life Insurance Company Limited, commonly known as China Life, is a Beijing-headquartered insurance company incorporated in China. Its principal business is the provision of life insurance and annuity products, with related health and accident insurance offerings. The company is the listed insurance operating entity associated with China Life Insurance (Group) Company and is one of the largest life insurers in the Chinese market. The company traces its institutional history to the establishment of the People's Insurance Company of China in 1949 and operates within the broader development of China's state-linked insurance sector. Its business has historically combined protection products, savings-oriented policies, retirement and annuity products, and insurance services distributed through a large domestic network. China Life's positioning is consequently broader than that of a narrowly specialized protection insurer: it serves individual policyholders, families, employers, and institutional customers across multiple stages of financial and retirement planning. China Life became an internationally traded company through listings in Hong Kong and New York in 2003, followed by an A-share listing in Shanghai in 2007. Its American depositary shares were later withdrawn from the New York Stock Exchange. In 2022, the company announced that ADS trading would end on 1 September, citing limited trading activity and the administrative costs associated with maintaining the listing. The underlying H shares continued to trade in Hong Kong. The company's main product categories include traditional and participating life insurance, term and whole-life protection, endowment and savings-linked policies, annuities, health insurance, and accident insurance. Publicly associated product lines include Guoshou Fu and Xinyu Jinsheng, although product availability and policy specifications can vary by period, distribution channel, and regulatory approval. As with other major Chinese insurers, China Life also participates in long-term investment and asset-management activities connected with the deployment of insurance funds. China Life has maintained a substantial domestic presence and has been described as China's largest life insurer by market share as of April 2023. It has also appeared in major international corporate rankings, including the Fortune Global 500 and Forbes Global 2000. In 2023, China Life and New China Life Insurance each invested 3.5 billion US dollars in the Honghu Private Securities Investment Fund, an initiative presented as a way to improve capital-use efficiency and expand long-term investment assets. The brand remains active, but its international footprint and corporate conduct have also attracted scrutiny. Reference material states that its Russian offices remained active in 2025 despite sanctions imposed on Russia after its full-scale invasion of Ukraine, and that the company advertised for employees there. This has prompted ethical questions about continued operations in that market. The company therefore combines the scale and institutional importance of a major Chinese financial brand with the regulatory, investment, geopolitical, and reputational issues associated with a large insurer operating across changing markets.

History

China Life Insurance Company's institutional background is connected to the formation of the People's Insurance Company of China in 1949, an important early milestone in the development of the modern Chinese insurance sector. Over subsequent decades, China's insurance industry evolved from a predominantly state-organized system into a large commercial market containing multiple national insurers, specialized financial institutions, and increasingly diverse distribution channels. China Life developed within this broader institutional transformation and became the listed insurance company associated with the China Life Insurance group. The company focuses primarily on life insurance and annuity business, while also offering health and accident coverage. Its portfolio reflects the multiple functions that life insurers perform in China: providing mortality and disability protection, accumulating policyholder savings, supporting retirement planning, and investing long-duration insurance funds. Its customer base includes individuals and families as well as institutional and employer-sponsored clients. The brand's scale has made it one of the most visible participants in China's insurance market and a major channel through which households purchase long-term financial-protection products. China Life expanded its access to international capital markets in 2003 through listings in Hong Kong and New York. It subsequently returned to the mainland equity market with a Shanghai A-share listing in 2007. The New York component was later discontinued. In 2022, the company announced the delisting of its American depositary shares, explaining that trading volumes were limited and that the costs of administering the ADS program were no longer justified. The H shares underlying the depositary receipts remained listed and traded in Hong Kong, preserving the company's principal overseas equity-market presence. The company has also used its balance sheet and investment platform to participate in long-term asset allocation. In 2023, China Life invested 3.5 billion US dollars in the Honghu Private Securities Investment Fund, alongside an equal investment from New China Life Insurance. The stated objective was to improve the efficiency of capital utilization and expand long-term investment assets. This activity illustrates the importance of investment management to the economics of a large life insurer, whose liabilities and policy obligations generally extend over long periods. China Life has been included in prominent corporate rankings, including the Fortune Global 500 and Forbes Global 2000. Reference material describes it as China's largest life insurer by market share as of April 2023. Its business is principally associated with China, although the company has maintained overseas operations. In 2025, continued activity by its Russian offices and recruitment in Russia attracted ethical criticism because of the sanctions and geopolitical consequences associated with Russia's invasion of Ukraine. That issue demonstrates how the company's international operations can create reputational and compliance questions beyond its core insurance business. Today, China Life remains an active, publicly traded insurer with a broad product architecture spanning life protection, annuities, health insurance, accident insurance, savings-oriented products, and retirement-related coverage. Its history reflects the institutional development of Chinese insurance, the shift toward public capital markets, and the increasingly important relationship between insurance underwriting and long-term investment management.

2023
Investment in Honghu fund
[1]China Life Insurance Companyen.wikipedia.org
China Life invested 3.5 billion US dollars in the Honghu Private Securities Investment Fund together with an equal investment by New China Life Insurance.
2022
American depositary shares scheduled for delisting
[1]China Life Insurance Companyen.wikipedia.org
China Life announced that its ADS program would end, citing low trading volume and the costs of maintaining the program, while its Hong Kong-listed H shares continued trading.
2007
Shanghai A-share listing
[1]China Life Insurance Companyen.wikipedia.org
The company expanded its public-market presence with a listing on the Shanghai Stock Exchange.
2003
Hong Kong and New York listings
[1]China Life Insurance Companyen.wikipedia.org
China Life became publicly traded in Hong Kong and New York through its H-share and American depositary share listings.
1949
Institutional predecessor established
[1]China Life Insurance Companyen.wikipedia.org
The company's institutional history is traced to the establishment of the People's Insurance Company of China, an important predecessor in the development of China's state-linked insurance sector.

Products and positioning

A large, comprehensive Chinese life-insurance provider serving protection, savings, retirement, health, and accident-insurance needs.

Protection insurance
Life insurance
China Life's core business comprises life-insurance policies designed to provide benefits associated with death, survival, or other insured life events. The portfolio can include protection-oriented and savings-oriented structures, serving individuals and families seeking long-term financial security.
Retirement and income insurance
Annuities
Annuity products convert premiums or accumulated policy value into scheduled benefits or income streams. They support retirement planning and other long-duration financial needs and are an important product category for a large life insurer.
Health insurance
Health insurance
China Life offers health-insurance coverage alongside its life business. These products address medical or health-related financial risks and broaden the company's relationship with policyholders beyond mortality protection.
Personal accident insurance
Accident insurance
Accident insurance provides coverage for specified accidental events and related consequences. Within China Life's broader portfolio, it complements life, health, and annuity products and can be sold through individual or institutional channels.
Life insurance product line
Guoshou Fu
Guoshou Fu is a product line publicly associated with China Life. It is included here as a branded offering rather than as a description of specific policy terms, which may differ by product version, market period, distribution channel, and regulatory approval.
Life and savings-oriented insurance product line
Xinyu Jinsheng
Xinyu Jinsheng is a branded offering associated with China Life and generally presented within the company's long-term insurance and savings-oriented product portfolio. Detailed benefits and availability are not specified in the supplied reference material.

Controversies

2025
Continued Russian operations amid sanctions
China Life's continued operation of Russian offices and reported recruitment activity in Russia, despite international sanctions following the invasion of Ukraine, generated ethical scrutiny. The issue concerns the reputational and geopolitical implications of maintaining commercial activity in that market; the supplied material does not establish a legal finding of wrongdoing by the company.
Source
2023
Former China Life Insurance Group chairman Wang Bin given death sentence with reprieve in first-instance bribery case
On September 12, 2023, the Jinan Intermediate People's Court sentenced Wang Bin, former chairman of China Life Insurance Group and former chairman of China Guangfa Bank, to death with a two-year reprieve, commuted to life imprisonment without parole. He was found to have accepted more than 325 million yuan in bribes and concealed more than 56.42 million yuan in overseas deposits; the bribery involved his positions at multiple financial institutions.
Source
2021
Some violations confirmed and personnel held accountable after employee report at Nenjiang sub-branch
In 2021, Zhang Naidan, a former employee of China Life, reported under her real name irregularities including falsification at the Nenjiang sub-branch. The company's investigation notice said some related issues were true; two people were removed from their posts and six were held accountable; regulators imposed penalties on the institutions involved. This entry recognizes only the issues confirmed by investigation and does not treat all the report's content as fact.
Source
2020
Liaoning regulator penalizes China Life’s Fushun branch over unapproved appointments
The Liaoning Banking and Insurance Regulatory Bureau issued an administrative penalty decision concerning China Life Insurance Company’s Fushun branch. According to the report, the branch allowed two individuals to perform management duties at its Dongzhou District sub-branch without regulatory approval. The supplied report does not state the penalty amount.
Source

Brand decisions

2023
Investment in the Honghu Private Securities Investment FundStrategy
Background
China Life and New China Life Insurance sought to improve the use of insurance capital and increase long-term investment assets.
Action taken
China Life invested 3.5 billion US dollars in the Honghu Private Securities Investment Fund, matching the investment made by New China Life Insurance.
Aftermath
The investment expanded the company's disclosed participation in long-term financial-asset allocation, although the supplied material does not report subsequent returns or performance.
Investment commitment. US$3.5 billion (2023)
Source
2022
Withdrawal of the American depositary share programStrategy
Background
The company stated that ADS trading volume was limited and that maintaining the program created administrative costs.
Action taken
China Life announced that its ADSs would be delisted, with 1 September 2022 intended to be the final trading day. The Hong Kong-listed H shares continued trading.
Aftermath
The decision reduced China Life's publicly traded US-market presence while leaving its Hong Kong listing in place.
Source

Recent events

Unconfirmed
GLP partners with China Life and China Co-Op Group to establish logistics fund[10]GLP partners with China Life and China Co-Op Group to establish logistics fundcaixinglobal.com
GLP Pte. Ltd. partnered with China Life and China Co-Op Group to set up the GLP Co-Op Development Fund, with an initial size of nearly 3 billion yuan and a target to raise up to 20 billion yuan in capital commitments.
2021-10-27
China Life expanded its donated microinsurance coverage in Tainan[11]中国人寿扩大捐助台南微型保险保障范围n.yam.com
Reported: 2021-10-26
China Life, Tainan's Social Affairs Bureau and Chaoxing Foundation cooperated to extend donated microinsurance to registered low- and middle-income residents in Tainan; the expanded coverage was scheduled to take effect on November 1, 2021.
2021-10-16
China Life appoints Yi Jianlian as brand ambassador[12]中国人寿聘请易建联担任品牌形象大使ent.people.com.cn
Reported: 2021-10-18
China Life formally appointed basketball player Yi Jianlian as a brand image ambassador at the CBA season opening event on October 16.
2021-10-16
China Life releases new CBA-season theme advertisement[12]中国人寿聘请易建联担任品牌形象大使ent.people.com.cn
Reported: 2021-10-18
China Life released a new theme advertisement starring Yi Jianlian at the opening game of the 2021–2022 CBA season on October 16.
Unconfirmed
China Life launches senior-friendly life insurance app version[13]中国人寿上线寿险APP“尊老版”promote.caixin.com
China Life launched a senior-friendly version of its life insurance app, with features including a simplified interface, voice guidance and services tailored to older customers.
Unconfirmed
China Life launches senior-friendly life insurance app mode[14]中国人寿上线寿险APP“尊老版”finance.cqnews.net
Reported: 2021-07-14
China Life launched a senior-friendly version of its life insurance app to improve service for older customers.
2021-06-11
China Life launches cancer-specific medication expense medical insurance[15]中国人寿推出恶性肿瘤特定药品费用医疗保险finance.shm.com.cn
China Life launched a medical insurance product covering specified medication expenses for people with malignant tumors. The article describes coverage for up to 60 specified medicines and eligible compensation of up to RMB 1.5 million for the stated example age group.
Unconfirmed
China Life launches cancer-specific medication expense medical insurance[16]中国人寿推出恶性肿瘤特定药品费用医疗保险insurance.jrj.com.cn
China Life Insurance Company Limited launched an insurance product covering specified medication expenses for cancer treatment.
Unconfirmed
China Life receives a service-excellence award[17]中国人寿获服务类“领跑企业”荣誉finance.shm.com.cn
China Life Insurance Company Limited received the “Leading Enterprise” honor in an evaluation organized by the China Quality Journey Promotion Association, which cited its service.
2020-12-28
China Life wins Smart Epidemic Prevention Special Award[18]中国人寿荣获“智慧抗疫特别奖”finance.cqnews.net
Reported: 2020-12-28
China Life Insurance Company Limited won the Smart Epidemic Prevention Special Award at the 2020 Golden Bell Awards for Data Intelligence Application Models.

Showing the 10 most recent.

Related entries

China Life Insurance Group